An interval of fewer than 30 days between the last immunotherapy dose and the liver transplant increases the rejection risk ...

Liver cancer often remains undetected until advanced stages. Learn about the causes and how you can protect yourself with ...

Discover the distinctive symptoms of liver pain, common underlying conditions, and effective treatment options to protect ...

Hepatocellular carcinoma (HCC) represents about 80 to 90% of cases of primary liver cancer. On a global level, 905,700 new ...

Doctors warn, fatty liver can lead to liver cancer if ignored! Here's how to prevent non-alcoholic fatty liver disease.

Here are the risks of alcohol consumption beyond liver damage, including its link to various cancers and other health ...

Liver cancer is the fourth most common cancer and the fourth leading cause of cancer-related deaths in the country.

A study published in Nature Aging has revealed a promising new drug candidate that may help combat metabolic dysfunction-associated steatotic liver disease (MASLD), a chronic liver condition that ...

Hepatocellular carcinoma (HCC) is the most common type of liver cancer in Switzerland and worldwide. Immunotherapy through ...

New research reveals distinct epidemiological trends in liver cancer across Mexico, with gender and regional variations ...

The peritoneal cavity, which contains the abdominal organs, is a less common but still potential site for breast cancer to ...